DigestRedComo funciona
Red
/
Empresas
Au
No verificado

Autobahn Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaPsiquiatríaSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
21/09/2026
Industria
Psiquiatría
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Óptica
Autobahn Therapeutics Reports AMPLIFY-BD Results for Elunetirom in Bipolar Depression, Highlighting Rapid, Robust, and Sustained Improvements in Depressive Symptoms and Functioning
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0
25/08/2026
Industria
Psiquiatría
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Autobahn Therapeutics Reports New Nonclinical Data Showing Elunetirom Rapidly Builds Synaptic Connections and Restores Cellular Energy Capacity in Neurons
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0
04/06/2026
Industria
Psiquiatría
Higiene alimentaria
Salud
Medicina - Varios
Farmacéutica
Biotecnología
Autobahn Therapeutics Reports Positive Phase 2 Topline Data for Elunetirom in Bipolar Depression, Demonstrating Rapid, Robust, and Durable Antidepressant Effects
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0
27/05/2026
Eventos
Biotecnología
Salud
Psiquiatría
Autobahn Therapeutics to Participate in Multiple Upcoming Investor Conferences
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0
26/05/2026
Psiquiatría
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Industria
Autobahn Therapeutics Announces U.S. FDA Fast Track Designation for Elunetirom, a CNS-Directed Thyroid Hormone Receptor Agonist, for the Adjunctive Treatment of Bipolar Depression
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0
20/05/2026
Ciencia
Biotecnología
Farmacéutica
Salud
Psiquiatría
Medicina - Varios
Eventos
Industria
Autobahn Therapeutics Presents New Preclinical Data at ASCP Annual Meeting Demonstrating Elunetirom Drives Robust Bioenergetic and Neuroplastic Improvements in Neuronal Cultures
Fuente
Autobahn Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0